Skip to Content

Five reasons why our HER2 (4B5) assay continues to be the trusted diagnostic assay of choice

Roche’s portfolio of immunohistochemistry (IHC) and in situ hybridization (ISH) breast cancer diagnostic assays provide high sensitivity, specificity and consistency
May 6, 2024 by
Five reasons why our HER2 (4B5) assay continues to be the trusted diagnostic assay of choice
Bio Synergy, VKP

Start writing here...

Read Next
How can an advanced, automated slide staining system improve efficiency and lab sustainability?
Improving operational efficiencies as well as reducing workflow demands with advanced systems helps free up staff for other, more critical tasks